Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > 1Qtr with Slides
View:
Post by Wino115 on Apr 14, 2021 8:27pm

1Qtr with Slides

If you didn't see the call, there were slides with it.  Some are useful to see.  You can skip to each slide and listen to just the ones you want to or just see the slides.  There is a Trogarzo customer satisfaction survey in there which is new.  They focus a lot of the AACR on the colorectal results which are a strong demonstration of the approach.  He makes one point in there toward the end of that slide that even the most recent ADCs suffer from often causing neutropenia and infections, so if they continue to show this safety data it will be huge versus all the ADCs in those indications, assuming it's equally or better in efficacy.  

1 Qtr Slide Presentation THTX
Comment by SPCEO1 on Apr 15, 2021 10:43am
Some thoughts on those slides: 1.) Marsolais and Leasure were ready to ask questions if there had been any. It sure would have been nice to get some additional color on the AACR presentation data from Christian and also would have been great to hear from our new head of global marketing. Since there is not much goign on outside the US right now, I would have liked to hear him explain why his ...more  
Comment by Wino115 on Apr 15, 2021 12:46pm
Exactly why they should solicit email questions from investors prior to the call and select the half dozen THEY want to chat about -- like Christian elaborating on AACR, etc..   They really need to do this. Paul has now seen that for a year, he is greated with either embarassing silence or really innane questions from the junior coverage analysts that miss the major emphasis of his strategy ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities